Aigen Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,732
| Closed | -$240K | – | 1029 |
|
|
2023
Q3 | $240K | Buy |
6,732
+2,312
| +52% | +$82.4K | 0.05% | 605 |
|
|
2023
Q2 | $204K | Buy |
+4,420
| New | +$204K | 0.03% | 616 |
|
|
2022
Q2 | – | Sell |
-13,982
| Closed | -$1.02M | – | 693 |
|
|
2022
Q1 | $1.02M | Buy |
+13,982
| New | +$1.02M | 0.18% | 158 |
|
|
2021
Q3 | – | Sell |
-7,478
| Closed | -$713K | – | 625 |
|
|
2021
Q2 | $713K | Buy |
7,478
+5,499
| +278% | +$524K | 0.12% | 179 |
|
|
2021
Q1 | $225K | Sell |
1,979
-9,338
| -83% | -$1.06M | 0.03% | 505 |
|
|
2020
Q4 | $1.57M | Sell |
11,317
-5,133
| -31% | -$711K | 0.2% | 127 |
|
|
2020
Q3 | $1.35M | Buy |
+16,450
| New | +$1.35M | 0.17% | 186 |
|
|
2020
Q2 | – | Sell |
-22,207
| Closed | -$987K | – | 1200 |
|
|
2020
Q1 | $987K | Sell |
22,207
-4,788
| -18% | -$213K | 0.13% | 216 |
|
|
2019
Q4 | $1.15M | Buy |
+26,995
| New | +$1.15M | 0.19% | 147 |
|